8fe0
From Proteopedia
(Difference between revisions)
m (Protected "8fe0" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Human GAR transformylase in complex with GAR substrate and AGF305 inhibitor== | |
| - | + | <StructureSection load='8fe0' size='340' side='right'caption='[[8fe0]], [[Resolution|resolution]] 2.22Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[8fe0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8FE0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8FE0 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GAR:GLYCINAMIDE+RIBONUCLEOTIDE'>GAR</scene>, <scene name='pdbligand=XSO:N-{5-[4-(2-amino-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]-3-fluoropyridine-2-carbonyl}-L-glutamic+acid'>XSO</scene></td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8fe0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8fe0 OCA], [https://pdbe.org/8fe0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8fe0 RCSB], [https://www.ebi.ac.uk/pdbsum/8fe0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8fe0 ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/PUR2_HUMAN PUR2_HUMAN] | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Dann III CE]] | ||
| + | [[Category: Wong-Roushar J]] | ||
Revision as of 06:56, 10 May 2023
Human GAR transformylase in complex with GAR substrate and AGF305 inhibitor
| |||||||||||
